News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Updates from CTOS with Thierry Alcindor
cqc-qcc.ca
Nov 22, 2024, 21:07

Updates from CTOS with Thierry Alcindor

The Life Raft Group shared a post on X:

“What’s CTOS all about?

Find out Monday, Nov. 25 at 12pm ET.

Thierry Alcindor of DFCI joins the LRG to talk about GIST relevant topics presented at this very significant annual meeting.

Register today.”

Thierry Alcindor

cancer CTOS DFCI GIST OncoDaily Oncology The Life Raft Group Thierry Alcindor
Special Coverage
Blog
Dec 22, 2024, 17:39
Mark Cobbold: Incredible Year in Cell Therapy and Immunotherapy at AstraZeneca
Insight
Dec 22, 2024, 17:36
Nicholas Hornstein: Something new in BRAF V600E mCRC
Insight
Dec 22, 2024, 17:32
Fawzi Abu Rous: We launched Lung Cancer Alliance in Arabic-Speaking MENA
Science
Dec 22, 2024, 17:26
Andrea De Giglio: The prognostic role of STK11 mutations in advanced NSCLC treated with first-line IO
Science
Dec 22, 2024, 17:23
Zeynep Irem Ozay: Assessing nectin-4 as a predictive biomarker in GU malignancies
Science
Dec 22, 2024, 17:18
Sam Klempner: Proof of principle in KRAS G12C mutation in colorectal cancer
Blog
Dec 22, 2024, 17:07
Rahul Shah: A great 6 months of dose-dense learning in leukemia clinic at MD Anderson Cancer Center
Science
Dec 22, 2024, 17:03
Andrea Apolo: Several accruing Clinical Trials for patients with Small Cell Bladder Cancer
Insight
Dec 22, 2024, 16:56
GSK Announced Landmark Results from FIRST Trial in First-Line Advanced Ovarian Cancer
Insight
Dec 22, 2024, 16:50
NIH Funds $3.2 Million Study on the Combination of Immune Blockade and Antiangiogenic Agents in Cancer Treatment
Insight
Dec 22, 2024, 16:46
Mayo Clinic Achieved Historic Milestone with 10 Organ Transplants in 24 Hours
Oncolibrary
Dec 22, 2024, 15:33
New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression